175 related articles for article (PubMed ID: 6238043)
1. Characterization of human lymphocyte subpopulations: alloreactive cytotoxic T-lymphocyte precursor and effector cells are phenotypically distinct from Leu 2+ suppressor cells.
Clement LT; Dagg MK; Landay A
J Clin Immunol; 1984 Sep; 4(5):395-402. PubMed ID: 6238043
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a phenotypically distinct subpopulation of Leu-2+ cells that suppresses T cell proliferative responses.
Landay A; Gartland GL; Clement LT
J Immunol; 1983 Dec; 131(6):2757-61. PubMed ID: 6227665
[TBL] [Abstract][Full Text] [Related]
3. Morphologic and phenotypic features of the subpopulation of Leu-2+ cells that suppresses B cell differentiation.
Clement LT; Grossi CE; Gartland GL
J Immunol; 1984 Nov; 133(5):2461-8. PubMed ID: 6237150
[TBL] [Abstract][Full Text] [Related]
4. Alloantigen-specific cytotoxic and suppressor T lymphocytes are derived from phenotypically distinct precursors.
Damle NK; Mohagheghpour N; Hansen JA; Engleman EG
J Immunol; 1983 Nov; 131(5):2296-300. PubMed ID: 6195259
[TBL] [Abstract][Full Text] [Related]
5. Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells.
Grimm EA; Ramsey KM; Mazumder A; Wilson DJ; Djeu JY; Rosenberg SA
J Exp Med; 1983 Mar; 157(3):884-97. PubMed ID: 6601174
[TBL] [Abstract][Full Text] [Related]
6. Human lymphokine-activated killer (LAK) cells: identification of two types of effector cells.
Tilden AB; Itoh K; Balch CM
J Immunol; 1987 Feb; 138(4):1068-73. PubMed ID: 3100627
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 2-activated human killer cells are derived from phenotypically heterogeneous precursors.
Damle NK; Doyle LV; Bradley EC
J Immunol; 1986 Nov; 137(9):2814-22. PubMed ID: 2944965
[TBL] [Abstract][Full Text] [Related]
8. Immunoregulatory T cells in man. Histamine-induced suppressor T cells are derived from a Leu 2+ (T8+) subpopulation distinct from that which gives rise to cytotoxic T cells.
Sansoni P; Silverman ED; Khan MM; Melmon KL; Engleman EG
J Clin Invest; 1985 Feb; 75(2):650-6. PubMed ID: 3156150
[TBL] [Abstract][Full Text] [Related]
9. T cell subpopulations defined by monoclonal antibodies after HLA-identical sibling marrow transplantation. II. Activated and functional subsets of helper-inducer and cytotoxic-suppressor subpopulations defined by two-colour fluorescence flow cytometry.
Atkinson K
Bone Marrow Transplant; 1986 Dec; 1(2):121-32. PubMed ID: 2971408
[TBL] [Abstract][Full Text] [Related]
10. Clonal and frequency analyses of tumor-infiltrating T lymphocytes from human solid tumors.
Miescher S; Whiteside TL; Moretta L; von Fliedner V
J Immunol; 1987 Jun; 138(11):4004-11. PubMed ID: 3108380
[TBL] [Abstract][Full Text] [Related]
11. Functional characterization of human T lymphocyte subsets distinguished by monoclonal anti-leu-8.
Kansas GS; Wood GS; Fishwild DM; Engleman EG
J Immunol; 1985 May; 134(5):2995-3002. PubMed ID: 3156924
[TBL] [Abstract][Full Text] [Related]
12. A human NK and K cell subset shares with cytotoxic T cells expression of the antigen recognized by antibody OKT8.
Perussia B; Fanning V; Trinchieri G
J Immunol; 1983 Jul; 131(1):223-31. PubMed ID: 6408172
[TBL] [Abstract][Full Text] [Related]
13. Differences in surface phenotype between cytolytic and non-cytolytic CD4+ T cells. MHC class II-specific cytotoxic T lymphocytes lack Leu 8 antigen and express CD2 in high density.
Takada S; Koide J; Engleman EG
J Immunol; 1989 May; 142(9):3038-44. PubMed ID: 2468710
[TBL] [Abstract][Full Text] [Related]
14. Quantitative and functional analysis of a human lymphocyte subset with the T-helper (Leu 3/T 4+) phenotype and natural killer (NK)-cell characteristics in patients with malignancy.
Velardi A; Clement LT; Grossi CE
J Clin Immunol; 1985 Sep; 5(5):329-39. PubMed ID: 2932461
[TBL] [Abstract][Full Text] [Related]
15. Further dissection of the functional heterogeneity within the OKT4+ and OKT8+ human T cell subsets.
Thomas Y; Rogozinski L; Rothman P; Rabbani LE; Andrews S; Irigoyen OH; Chess L
J Clin Immunol; 1982 Jul; 2(3 Suppl):8S-14S. PubMed ID: 6215426
[TBL] [Abstract][Full Text] [Related]
16. Antibodies to membrane structures that distinguish suppressor/cytotoxic and helper T lymphocyte subpopulations block the mixed leukocyte reaction in man.
Engleman EG; Benike CJ; Glickman E; Evans RL
J Exp Med; 1981 Jul; 154(1):193-8. PubMed ID: 6454755
[TBL] [Abstract][Full Text] [Related]
17. Antigenic, functional, and molecular genetic studies of human natural killer cells and cytotoxic T lymphocytes not restricted by the major histocompatibility complex.
Lanier LL; Le AM; Cwirla S; Federspiel N; Phillips JH
Fed Proc; 1986 Nov; 45(12):2823-8. PubMed ID: 3095151
[TBL] [Abstract][Full Text] [Related]
18. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes.
Lanier LL; Le AM; Civin CI; Loken MR; Phillips JH
J Immunol; 1986 Jun; 136(12):4480-6. PubMed ID: 3086432
[TBL] [Abstract][Full Text] [Related]
19. The immunosuppressive activity of L-leucyl-L-leucine methyl ester: selective ablation of cytotoxic lymphocytes and monocytes.
Thiele DL; Lipsky PE
J Immunol; 1986 Feb; 136(3):1038-48. PubMed ID: 2934477
[TBL] [Abstract][Full Text] [Related]
20. Antigen-specific suppressor T lymphocytes in man make use of the same set of surface molecules as do cytolytic T lymphocytes: roles of Leu-2/T8, Leu-4/T3, Leu-5/T11, LFA-1 molecules.
Damle NK; Fishwild DM; Engleman EG
J Immunol; 1985 Sep; 135(3):1724-30. PubMed ID: 3160777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
